“Looking for the very highest quality products and the consistency of a high-tech pharmaceuticals operation? Vida expects to file its licensing application before the end of April, a schedule that should allow it to have the necessary license in hand by the third quarter of this year. In the meantime, the company is raising $1.5 million at $.25 per share. That represents a market value of only $6 million for a company that now owns a 315,000-square-foot production plant with a replacement value estimated at $30 million. Personally, I think this will turn out to be an extraordinary investment. In less than a year’s time, this $.25 financing round is going to look extremely cheap.”
(Visited 45 times, 1 visits today)
Related posts:
Android SDK Released - Bitcoin Payment In Your Own Android App
Third Maryland Jurisdiction Forced To Refund Illegal Photo Tickets
World’s first affordable powered exoskeleton is almost here
China to ditch US consulting firms over suspected espionage
Michigan's Allegan County Passes Anti-NDAA Resolution
They’re Coming for Your Accounts
Merck Has Some Explaining To Do Over Its MMR Vaccine Claims
4 Little-Known Facts about Immigrants and Company Founders
Reid: 'Anarchists have taken over' in Congress
Australia And China To Enable Direct Currency Convertibility
A Secret Catalogue of Government Gear for Spying on Your Cellphone
Spain Shuts Down Google, Confronts the Internet
Why You Shouldn’t Gamble With Uncle Sam
Perception vs. Experience: Misconceptions about Puerto Rico
Cops Taser Then Shoot Man to Death After Family Calls 911 for Help for His Depression